2) Diabetic vascular complication
糖尿病血管并发症
1.
Effect of coixan on expression of NO and iNOS mRNA of aorta in rats of experimental diabetic vascular complication;
薏苡仁多糖对糖尿病血管并发症大鼠NO及主动脉iNOS基因表达的影响
2.
Diabetic vascular complications are the main cause of cripples and death of the diabetic patients,and the hereditary factor might play the vital role in the morbidity process of complications.
糖尿病血管并发症是糖尿病患者主要的致残、致死原因,遗传因素可能在并发症的发病过程中发挥着重要的作用。
3.
Methods The in vitro cell-injuring model of diabetic vascular complication was used to observe the cyto-morphology changes, the cell growth vitalis and the contents of nitrogen monoxidum(NO), endothelin-1(ET-1), tissue-type plasminogen activator(tPA) and its inhibitor(PAI) in the conditioned medium after respectively adding three dose ZGE a.
方法采用2型糖尿病血管并发症细胞研究模型,观察不同剂量左归降糖灵及达美康作用后细胞形态学、细胞生长活力及条件培养液中NO、ET-1、tPA、PAI-1含量的变化。
3) Diabetic cardiovascular complications
糖尿病慢性血管并发症
4) Macrovascular Diseases
糖尿病大血管并发症
1.
The Research of the Association of the Level of Serum BH4 and Macrovascular Diseases induced by diabetes mellitus;
血浆BH4水平与2型糖尿病大血管并发症的相关性研究
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条